Literature DB >> 15071496

Dystroglycan, a scaffold for the ERK-MAP kinase cascade.

Heather J Spence1, Amardeep S Dhillon, Marian James, Steven J Winder.   

Abstract

Dystroglycan is an important cell adhesion receptor linking the actin cytoskeleton, via utrophin and dystrophin, to laminin in the extracellular matrix. To identify adhesion-related signalling molecules associated with dystroglycan, we conducted a yeast two-hybrid screen and identified mitogen-activated protein (MAP) kinase kinase 2 (MEK2) as a beta-dystroglycan interactor. Pull-down experiments and localization studies substantiated a physiological link between beta-dystroglycan and MEK and localized MEK with dystroglycan in membrane ruffles. Moreover, we also identified active extracellular signal-regulated kinase (ERK), the downstream kinase from MEK, as another interacting partner for beta-dystroglycan and localized both active ERK and dystroglycan to focal adhesions in fibroblast cells. These studies suggest a role for dystroglycan as a multifunctional adaptor or scaffold capable of interacting with components of the ERK-MAP kinase cascade including MEK and ERK. These findings have important implications for our understanding of the role of dystroglycan in normal cellular processes and in disease states such as muscular dystrophy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15071496      PMCID: PMC1299052          DOI: 10.1038/sj.embor.7400140

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  28 in total

1.  Phosphorylation of MAP kinases by MAP/ERK involves multiple regions of MAP kinases.

Authors:  J L Wilsbacher; E J Goldsmith; M H Cobb
Journal:  J Biol Chem       Date:  1999-06-11       Impact factor: 5.157

2.  Protein production in three different expression vectors from a single polymerase chain reaction product.

Authors:  S J Winder; J Kendrick-Jones
Journal:  Anal Biochem       Date:  1995-10-10       Impact factor: 3.365

3.  Chimaeric mice deficient in dystroglycans develop muscular dystrophy and have disrupted myoneural synapses.

Authors:  P D Côté; H Moukhles; M Lindenbaum; S Carbonetto
Journal:  Nat Genet       Date:  1999-11       Impact factor: 38.330

4.  Association of the dystroglycan complex isolated from bovine brain synaptosomes with proteins involved in signal transduction.

Authors:  M Cavaldesi; G Macchia; S Barca; P Defilippi; G Tarone; T C Petrucci
Journal:  J Neurochem       Date:  1999-04       Impact factor: 5.372

5.  Localization of utrophin and aciculin at sites of cell-matrix and cell-cell adhesion in cultured cells.

Authors:  A M Belkin; K Burridge
Journal:  Exp Cell Res       Date:  1995-11       Impact factor: 3.905

6.  Association of Sos Ras exchange protein with Grb2 is implicated in tyrosine kinase signal transduction and transformation.

Authors:  S E Egan; B W Giddings; M W Brooks; L Buday; A M Sizeland; R A Weinberg
Journal:  Nature       Date:  1993-05-06       Impact factor: 49.962

7.  Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP.

Authors:  K Yeung; T Seitz; S Li; P Janosch; B McFerran; C Kaiser; F Fee; K D Katsanakis; D W Rose; H Mischak; J M Sedivy; W Kolch
Journal:  Nature       Date:  1999-09-09       Impact factor: 49.962

8.  MP1: a MEK binding partner that enhances enzymatic activation of the MAP kinase cascade.

Authors:  H J Schaeffer; A D Catling; S T Eblen; L S Collier; A Krauss; M J Weber
Journal:  Science       Date:  1998-09-11       Impact factor: 47.728

9.  Epidermal growth factor regulates p21ras through the formation of a complex of receptor, Grb2 adapter protein, and Sos nucleotide exchange factor.

Authors:  L Buday; J Downward
Journal:  Cell       Date:  1993-05-07       Impact factor: 41.582

10.  Interaction of chromosome-6-encoded dystrophin related protein with the extracellular matrix.

Authors:  T S Khurana; L M Kunkel; A D Frederickson; S Carbonetto; S C Watkins
Journal:  J Cell Sci       Date:  1995-01       Impact factor: 5.285

View more
  71 in total

1.  PTEN inhibition improves wound healing in lung epithelia through changes in cellular mechanics that enhance migration.

Authors:  Cosmin Mihai; Shengying Bao; Ju-Ping Lai; Samir N Ghadiali; Daren L Knoell
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-10-28       Impact factor: 5.464

2.  Absence of post-phosphoryl modification in dystroglycanopathy mouse models and wild-type tissues expressing non-laminin binding form of α-dystroglycan.

Authors:  Atsushi Kuga; Motoi Kanagawa; Atsushi Sudo; Yiumo Michael Chan; Michiko Tajiri; Hiroshi Manya; Yamato Kikkawa; Motoyoshi Nomizu; Kazuhiro Kobayashi; Tamao Endo; Qi L Lu; Yoshinao Wada; Tatsushi Toda
Journal:  J Biol Chem       Date:  2012-01-23       Impact factor: 5.157

3.  Characterization of the interaction of lassa fever virus with its cellular receptor alpha-dystroglycan.

Authors:  Stefan Kunz; Jillian M Rojek; Mar Perez; Christina F Spiropoulou; Michael B A Oldstone
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

4.  Laminin-6 assembles into multimolecular fibrillar complexes with perlecan and participates in mechanical-signal transduction via a dystroglycan-dependent, integrin-independent mechanism.

Authors:  Jonathan C R Jones; Kimberly Lane; Susan B Hopkinson; Emilia Lecuona; Robert C Geiger; David A Dean; Eduardo Correa-Meyer; Meredith Gonzales; Kevin Campbell; Jacob I Sznajder; Scott Budinger
Journal:  J Cell Sci       Date:  2005-05-31       Impact factor: 5.285

Review 5.  The congenital muscular dystrophies: recent advances and molecular insights.

Authors:  Jerry R Mendell; Daniel R Boué; Paul T Martin
Journal:  Pediatr Dev Pathol       Date:  2006 Nov-Dec

6.  Modulation of p38 mitogen-activated protein kinase cascade and metalloproteinase activity in diaphragm muscle in response to free radical scavenger administration in dystrophin-deficient Mdx mice.

Authors:  Karim Hnia; Gerald Hugon; François Rivier; Ahmed Masmoudi; Jacques Mercier; Dominique Mornet
Journal:  Am J Pathol       Date:  2007-02       Impact factor: 4.307

7.  Mice lacking dystrophin or alpha sarcoglycan spontaneously develop embryonal rhabdomyosarcoma with cancer-associated p53 mutations and alternatively spliced or mutant Mdm2 transcripts.

Authors:  Karen Fernandez; Yelda Serinagaoglu; Sue Hammond; Laura T Martin; Paul T Martin
Journal:  Am J Pathol       Date:  2009-12-17       Impact factor: 4.307

8.  Muscular dystrophy associated with alpha-dystroglycan deficiency in Sphynx and Devon Rex cats.

Authors:  Paul T Martin; G Diane Shelton; Peter J Dickinson; Beverly K Sturges; Rui Xu; Richard A LeCouteur; Ling T Guo; Robert A Grahn; Harriet P Lo; Kathryn N North; Richard Malik; Eva Engvall; Leslie A Lyons
Journal:  Neuromuscul Disord       Date:  2008-11-05       Impact factor: 4.296

9.  Loss of alpha-dystroglycan laminin binding in epithelium-derived cancers is caused by silencing of LARGE.

Authors:  Daniel Beltrán-Valero de Bernabé; Kei-Ichiro Inamori; Takako Yoshida-Moriguchi; Christine J Weydert; Hollie A Harper; Tobias Willer; Michael D Henry; Kevin P Campbell
Journal:  J Biol Chem       Date:  2009-02-24       Impact factor: 5.157

10.  Ligation of alpha-dystroglycan on podocytes induces intracellular signaling: a new mechanism for podocyte effacement?

Authors:  Nils P J Vogtländer; Henk Jan Visch; Marinka A H Bakker; Jo H M Berden; Johan van der Vlag
Journal:  PLoS One       Date:  2009-06-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.